GlgE is identified as a maltosyltransferase that catalyzes the polymerization step in a previously undescribed pathway in Mycobacterium tuberculosis for converting trehalose to α-glucan. A combination of traditional and chemical genetic strategies suggest GlgE to be a viable therapeutic target.
- Rainer Kalscheuer
- Karl Syson
- William R Jacobs Jr
